Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2019 Filed May 15, 2019 20:57 UTC |
Sloves AndrewDirector
|
PurchaseCommon Stock | 400 | $16.65 | $6,660.00 |
DisclosureSEC source: 0001209191-19-030064 · doc4.xml · nonDerivative · entry 5 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for Son Disclosed balance after: 1,100 Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:57 UTC |
Sloves AndrewDirector
|
PurchaseCommon Stock | 400 | $16.66 | $6,664.00 |
DisclosureSEC source: 0001209191-19-030064 · doc4.xml · nonDerivative · entry 4 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for Daughter Disclosed balance after: 1,900 Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:57 UTC |
Sloves AndrewDirector
|
PurchaseCommon Stock | 1,000 | $16.65 | $16,650.00 |
DisclosureSEC source: 0001209191-19-030064 · doc4.xml · nonDerivative · entry 3 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for Daughter Disclosed balance after: 2,500 Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:26 UTC |
Saltzman DavidDirector
|
PurchaseCommon Stock | 14,174 | $16.66 | $236,138.84 |
DisclosureSEC source: 0001209191-19-027710 · doc4.xml · nonDerivative · entry 1 Saltzman David · CIK 0001574248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,887 F1 · price: The shares were purchased in multiple transactions and the price reported is a weighted average. The purchase price ranged from $16.65 to $16.66. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2019 Filed May 1, 2019 21:07 UTC |
LENEHAN PAMELA FDirector
|
GrantStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $16.81 | $0.00 |
DisclosureSEC source: 0001209191-19-026805 · doc4.xml · derivative · entry 1 LENEHAN PAMELA F · CIK 0001202481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-04-30 F1 · price: Non-officer Director Stock options were granted pursuant to the issuer's Nonqualified Option and Incentive Award Plan (the "Plan"). Such options are fully vested in accordance with the terms of the Plan. F1 · derivative.exercise_date: Non-officer Director Stock options were granted pursuant to the issuer's Nonqualified Option and Incentive Award Plan (the "Plan"). Such options are fully vested in accordance with the terms of the Plan. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $17.32 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 8 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock, par value $0.01 per share · 75,000 shares Expires 2028-11-08 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $17.32 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 7 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock, par value $0.01 per share · 500,000 shares Expires 2028-11-05 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 2,046 | $0.00 Strike: $18.57 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 6 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,046 Underlying: Common Stock, par value $0.01 per share · 2,046 shares Expires 2028-09-06 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $18.54 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 5 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock, par value $0.01 per share · 5,000 shares Expires 2028-08-31 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 236 | $0.00 Strike: $18.45 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 4 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236 Underlying: Common Stock, par value $0.01 per share · 236 shares Expires 2028-08-24 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 2,551 | $0.00 Strike: $18.50 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 3 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,551 Underlying: Common Stock, par value $0.01 per share · 2,551 shares Expires 2028-08-23 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $17.10 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 2 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock, par value $0.01 per share · 75,000 shares Expires 2028-01-23 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 12:09 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $17.10 | $0.00 |
DisclosureSEC source: 0001209191-19-018307 · doc4.xml · derivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock, par value $0.01 per share · 500,000 shares Expires 2028-01-19 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 11:55 UTC |
Nierenberg MichaelDirector · CEO and President
|
PurchaseCommon Stock, par value $0.01 per share | 60,000 | $16.50 | $990,000.00 |
DisclosureSEC source: 0001209191-19-012819 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 995,352 F1 · kind: Shares were purchased in connection with the Issuer's public offering of common stock. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 01:17 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 7,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001550 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,346 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $14.21 on 12/31/2018. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 20:22 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 7,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001559 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,689 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $14.21 on December 31, 2018. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 20:19 UTC |
Tyson Alan L.Director
|
GrantCommon Stock | 7,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001557 · doc4.xml · nonDerivative · entry 1 Tyson Alan L. · CIK 0001536275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,473 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $14.21 on December 31, 2018. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 01:14 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 7,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001539 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,481 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $14.21 on December 31, 2018. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 21:09 UTC |
Nierenberg MichaelDirector · CEO and President
|
Exercise / conversionStock Option (right to buy) · Derivative | 558,708 | $0.00 Strike: $15.38 | $0.00 |
DisclosureSEC source: 0001209191-18-039520 · doc4.xml · derivative · entry 8 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 558,708 shares Expires 2025-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 3) F4 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of tandem awards to the total number of related options (including options underlying such tandem awards) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F5 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 21:09 UTC |
Nierenberg MichaelDirector · CEO and President
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,150,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001209191-18-039520 · doc4.xml · derivative · entry 7 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 1,150,000 shares Expires 2025-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 3) F4 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of tandem awards to the total number of related options (including options underlying such tandem awards) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F5 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 21:09 UTC |
Nierenberg MichaelDirector · CEO and President
|
SaleCommon Stock, par value $0.01 per share | 339,177 | $18.30 | $6,206,939.10 |
DisclosureSEC source: 0001209191-18-039520 · doc4.xml · nonDerivative · entry 4 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,352 F2 · kind: All of the shares sold were issued pursuant to a concurrent exercise of outstanding options. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 21:09 UTC |
Nierenberg MichaelDirector · CEO and President
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,369,531 | $18.66 | $25,555,448.46 |
DisclosureSEC source: 0001209191-18-039520 · doc4.xml · nonDerivative · entry 3 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,274,529 F1 · kind: No shares were sold. Reflects deemed surrender of shares to satisfy the exercise price due upon exercise of the associated options. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 21:09 UTC |
Nierenberg MichaelDirector · CEO and President
|
Exercise / conversionCommon Stock, par value $0.01 per share | 558,708 | $15.38 | $8,592,929.04 |
DisclosureSEC source: 0001209191-18-039520 · doc4.xml · nonDerivative · entry 2 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 21:09 UTC |
Nierenberg MichaelDirector · CEO and President
|
Exercise / conversionCommon Stock, par value $0.01 per share | 1,150,000 | $14.75 | $16,962,500.00 |
DisclosureSEC source: 0001209191-18-039520 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,085,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2018 Filed May 30, 2018 16:23 UTC |
JACOBS DOUGLAS LDirector
|
GrantCommon Stock | 5,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034125 · doc4.xml · nonDerivative · entry 1 JACOBS DOUGLAS L · CIK 0001195064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,213 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $18.10 on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 20:28 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 5,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034129 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,308 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $18.10 on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 16:26 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 5,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034128 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,651 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $18.10 on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 16:22 UTC |
Tyson Alan L.Director
|
GrantCommon Stock | 5,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034123 · doc4.xml · nonDerivative · entry 1 Tyson Alan L. · CIK 0001536275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,435 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $18.10 on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 20:31 UTC |
Saltzman DavidDirector
|
GrantCommon Stock | 5,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034133 · doc4.xml · nonDerivative · entry 1 Saltzman David · CIK 0001574248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,713 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $18.10 on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 20:19 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 5,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034118 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,443 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $18.10 on May 25, 2018. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 21:41 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 1,130,916 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006023 · doc4.xml · derivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130,916 Underlying: Common Stock, par value $0.01 per share · 1,130,916 shares Expires 2027-02-28 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 21:43 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 4,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001975 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,783 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $17.44 per share on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 16:48 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 6,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001980 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,126 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $17.44 on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 16:52 UTC |
Tyson Alan L.Director
|
GrantCommon Stock | 6,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001990 · doc4.xml · nonDerivative · entry 1 Tyson Alan L. · CIK 0001536275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,910 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $17.44 on January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 21:50 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 6,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001984 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,918 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $17.44 on January 3, 2018. Read SEC document |
| May 26, 2017 Filed May 31, 2017 16:15 UTC |
JACOBS DOUGLAS LDirector
|
GrantCommon Stock | 4,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036413 · doc4.xml · nonDerivative · entry 1 JACOBS DOUGLAS L · CIK 0001195064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,688 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $16.55 on May 26, 2017. Read SEC document |
| May 26, 2017 Filed May 31, 2017 20:19 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 4,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036424 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,483 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $16.55 per share on May 26, 2017. Read SEC document |
| May 26, 2017 Filed May 31, 2017 16:31 UTC |
Tyson Alan L.Director
|
GrantCommon Stock | 4,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036453 · doc4.xml · nonDerivative · entry 1 Tyson Alan L. · CIK 0001536275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,316 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $16.55 on May 26, 2017. Read SEC document |
| May 26, 2017 Filed May 31, 2017 16:22 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 4,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036432 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,532 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock prices was $16.55 on May 26, 2017. Read SEC document |
| May 26, 2017 Filed May 31, 2017 20:27 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 4,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036445 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,324 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $16.55 on May 26, 2017. Read SEC document |
| May 26, 2017 Filed May 31, 2017 20:24 UTC |
Saltzman DavidDirector
|
GrantCommon Stock | 4,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036439 · doc4.xml · nonDerivative · entry 1 Saltzman David · CIK 0001574248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,188 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $16.55 on May 26, 2017. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 21:24 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
PurchaseCommon Stock, par value $0.01 per share | 8,000 | $15.00 | $120,000.00 |
DisclosureSEC source: 0001209191-17-008052 · doc4.xml · nonDerivative · entry 3 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for daughter Disclosed balance after: 23,850 F1 · kind: Shares were purchased in connection with the Issuer's public offering of common stock. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 21:24 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
PurchaseCommon Stock, par value $0.01 per share | 8,000 | $15.00 | $120,000.00 |
DisclosureSEC source: 0001209191-17-008052 · doc4.xml · nonDerivative · entry 2 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for son Disclosed balance after: 24,400 F1 · kind: Shares were purchased in connection with the Issuer's public offering of common stock. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 21:24 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
PurchaseCommon Stock, par value $0.01 per share | 2,600 | $15.00 | $39,000.00 |
DisclosureSEC source: 0001209191-17-008052 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,352 F1 · kind: Shares were purchased in connection with the Issuer's public offering of common stock. Read SEC document |
| February 03, 2017 Filed Feb 17, 2017 22:41 UTC |
Nierenberg MichaelDirector · CEO and President
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001209191-17-012284 · doc4.xml · derivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock, par value $0.01 per share · 400,000 shares Expires 2026-08-31 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in equal monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in equal monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in generally equal monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 18:19 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 4,500 | $15.29 | $68,805.00 |
DisclosureSEC source: 0001209191-17-007272 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 23:28 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 700 | $15.38 | $10,766.00 |
DisclosureSEC source: 0001209191-17-007277 · doc4.xml · nonDerivative · entry 5 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for Son Disclosed balance after: 700 F1 · price: The shares were purchased in multiple transactions and the price reported is a weighted average. The purchase price ranged from $15.3750 to $15.3775. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 23:28 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 500 | $15.38 | $7,690.00 |
DisclosureSEC source: 0001209191-17-007277 · doc4.xml · nonDerivative · entry 4 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for Daughter Disclosed balance after: 1,500 Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 23:28 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 10,000 | $15.34 | $153,400.00 |
DisclosureSEC source: 0001209191-17-007277 · doc4.xml · nonDerivative · entry 2 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Sloves Family Trust Disclosed balance after: 20,000 Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:36 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 4,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000958 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,951 F1 · price: Shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $15.81 on January 3, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.